The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021Sarah Mbaeyi, Kathleen Dooling, Danielle Moulia et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 180
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021Kate R. Woodworth, Sara E. Oliver, Danielle Moulia et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 174
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021Megan Wallace, Sara E. Oliver, Kate R. Woodworth et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 146
SARS Surveillance during Emergency Public Health Response, United States, March–July 2003Stephanie J. Schrag, Mary E. Chamberland, John T. Brooks et al.|Emerging infectious diseases|2004Cited by 39